Experienced in Scleroderma

Benjamin Misselwitz

Bern, BE, CH 
Experienced in Scleroderma
Bern, BE, CH 
OverviewLocationsClinical Research

Overview

Benjamin Misselwitz practices in Bern, Switzerland. Mr. Misselwitz is rated as an Experienced expert by MediFind in the treatment of Scleroderma. His top areas of expertise are Viral Gastroenteritis, Lactose Intolerance, Colitis, Thrombectomy, and Colonoscopy.

His clinical research consists of co-authoring 153 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Scleroderma.

Gender
Male

Locations

Bern, BE, Switzerland
Other Locations
Zurich, ZH, Switzerland
Wetzikon, ZH 3010, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
Enrollment Status: Active_not_recruiting
Publish Date: October 10, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
Enrollment Status: Active_not_recruiting
Publish Date: April 18, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
Networks of Bacterium-Metabolite Interactions in the Small Intestine
Networks of Bacterium-Metabolite Interactions in the Small Intestine
Enrollment Status: Terminated
Publish Date: December 11, 2024
Intervention Type: Other
Study Phase: Not Applicable
Studying the Impact of a Low Carbohydrate Diet on the Small Intestinal Microbiota
Studying the Impact of a Low Carbohydrate Diet on the Small Intestinal Microbiota
Enrollment Status: Terminated
Publish Date: December 09, 2024
Intervention Type: Other
Study Phase: Not Applicable
Prospective, Non-interventional, Observational Study in Patients With IBD Receiving IV or SC Vedolizumab Therapy to Observe Route of Administration Choices and Outcomes (VARIETY-Switzerland)
Prospective, Non-interventional, Observational Study in Patients With IBD Receiving IV or SC Vedolizumab Therapy to Observe Route of Administration Choices and Outcomes (VARIETY-Switzerland)
Enrollment Status: Completed
Publish Date: July 19, 2024
Normal Values for Gastric Emptying in a 13C-octanoate Breath Test Using a Solid Test Meal
Normal Values for Gastric Emptying in a 13C-octanoate Breath Test Using a Solid Test Meal
Enrollment Status: Completed
Publish Date: July 05, 2018
Intervention Type: Other
Study Phase: Not Applicable
Effects of Position and a Test Meal on Esophago-gastric Junction Morphology and Function Assessed by High-resolution Impedance Manometry (HRM)
Effects of Position and a Test Meal on Esophago-gastric Junction Morphology and Function Assessed by High-resolution Impedance Manometry (HRM)
Enrollment Status: Completed
Publish Date: July 03, 2018
Intervention Type: Other
View 7 Less Clinical Trials

153 Total Publications

Celiac disease
Celiac disease
Journal: MMW Fortschritte der Medizin
Published: August 07, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Misselwitz's expertise for a condition
ConditionClose
    View All 40 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile